Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine

Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005 and 2013. During this period, the Meningitis Vaccine Project (MVP) accumulated substantial experience in the ethical conduct of research to t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Infect Dis
Huvudupphovsmän: Martellet, Lionel, Sow, Samba O., Diallo, Aldiouma, Hodgson, Abraham, Kampmann, Beate, Hirve, Siddhivinayak, Tapia, Milagritos, Haidara, Fadima Cheick, Ndiaye, Assane, Diarra, Bou, Ansah, Patrick Odum, Akinsola, Adebayo, Idoko, Olubukola T., Adegbola, Richard A., Bavdekar, Ashish, Juvekar, Sanjay, Viviani, Simonetta, Enwere, Godwin C., Marchetti, Elisa, Chaumont, Julie, Makadi, Marie-Francoise, Pallardy, Flore, Kulkarni, Prasad S., Preziosi, Marie-Pierre, LaForce, F. Marc
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2015
Ämnen:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639500/
https://ncbi.nlm.nih.gov/pubmed/26553670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ598
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk